Keywords: access, pharmaceuticals, start, phase, ii, trials, topical

Access Pharmaceuticals To Start Phase II Trials of Topical Acne Drug

Article | 12 November 1998

Print This

Access Pharmaceuticals will shortly start Phase II trials of itstopical acne drug ResiDerm A, consisting of clindamycin formulated using its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in